Oncology Cardiology / Cardiovascular Respiratory / COPD / Asthma Infectious Disease Gastroenterology Diabetes / Metabolic Neurology Rheumatology Women's Health Mental Health / Psychiatry Dermatology Rare Diseases Men's Health
Clinical Trial Active — Not Recruiting NCT05957276

Global Patient Registry of Inherited Retinal Diseases

Global Patient Registry of Inherited Retinal Diseases — Active Not Recruiting • NCT05957276.

📅 06 Jul 2026 ⏱ 1 min read
Active — Not Recruiting
Check the registry for current status and eligibility criteria.
Status
Active — Not Recruiting
NCT ID
NCT05957276
Start
2023-08-31
Completion
2026-07-03
ClinicaliQ Trial Snapshot
  • Global Patient Registry of Inherited Retinal Diseases — Active Not Recruiting • NCT05957276.
  • This registry collects data on inherited retinal disease patients worldwide to understand disease progression and improve how doctors manage these conditions.

Verify eligibility, endpoints and current status on the original ClinicalTrials.gov registry before acting on this summary.

Use This Page For
  • Quick orientation before opening the registry record.
  • Checking recruitment status, phase and sponsor at a glance.
  • Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying

The purpose of this study is to better understand the natural history of Inherited Retinal Disease (IRD) and help inform patient management. Conditions: Inherited Retinal Diseases Interventions: Standard of Care Lead Sponsor: Janssen Research & Development, LLC Planned Enrollment: 888 participants

Full Trial Details
View this trial on the source registry
Eligibility criteria, protocol, and results when available
View Trial ↗
Share: Twitter/X LinkedIn